Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Advance Solid Tumors
Interventions
DRUG

Iniparib (SAR240550 - BSI-201)

"Pharmaceutical form:sterile aqueous solution~Route of administration: intravenous"

DRUG

Gemcitabine

"Pharmaceutical form:sterile aqueous solution~Route of administration: intravenous"

DRUG

Carboplatin

"Pharmaceutical form:sterile aqueous solution~Route of administration: intravenous"

Trial Locations (2)

Unknown

Sanofi-Aventis Investigational Site Number 392001, Kobe

Sanofi-Aventis Investigational Site Number 392002, Matsuyama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY